Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Moodys
UBS
Deloitte
Argus Health
Chinese Patent Office
AstraZeneca
US Army

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,914,396

« Back to Dashboard

Summary for Patent: 5,914,396
Title: 2'-O-modified nucleosides and phosphoramidites
Abstract:2'-O-Modified nucleosides, nucleotides, and oligonucleotides. These 2'-O-modified oligonucleotides are resistant to nuclease digestion and can effectively hybridize to a complementary polynucleotide.
Inventor(s): Cook; Phillip Dan (San Marcos, CA), Guinosso; Charles John (Vista, CA)
Assignee: ISIS Pharmaceuticals, Inc. (Carlsbad, CA)
Application Number:08/373,298
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 5,914,396

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,914,396

PCT Information
PCT FiledJuly 20, 1993PCT Application Number:PCT/US93/06807
PCT Publication Date:February 03, 1994PCT Publication Number: WO94/02501

International Family Members for US Patent 5,914,396

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 154947 ➤ Try a Free Trial
Austria 159025 ➤ Try a Free Trial
Austria 160353 ➤ Try a Free Trial
Austria 168561 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cerilliant
Dow
Boehringer Ingelheim
Queensland Health
AstraZeneca
Fish and Richardson
Accenture
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.